FDA Inspection 983085 — Shilpa Medicare Limited
The FDA completed an inspection of Shilpa Medicare Limited on Jul 26, 2016 in Jadcherla, Mahabubnagar District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jadcherla, Mahabubnagar District (India)